Servier Acquires Potential Treatment for Fragile X Syndrome
09 Sep 2025 //
PR NEWSWIRE
Kaerus Bio`s KER-0193 granted Orphan & Rare Pediatric Designation
14 May 2025 //
PR NEWSWIRE
Kaerus Bioscience Completes Phase 1 Trial for Fragile X Syndrome
11 Mar 2025 //
GLOBENEWSWIRE